Covered recipient · General Payments record
RASHID ANSARI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$601.25
- Reported across 31 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $254.84 | 12 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $73.78 | 4 |
| Lilly USA, LLC | $41.57 | 2 |
| Acerta Pharma LLC | $39.42 | 2 |
| ABBVIE INC. | $34.67 | 1 |
| Exact Sciences Corporation | $23.95 | 1 |
| Abbott Laboratories | $22.87 | 1 |
| Novo Nordisk AS | $18.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.87 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241003118 | CMS |
| ABBVIE INC. | $34.67 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201422149 | CMS |
| Amgen Inc. | $23.83 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228261879 | CMS |
| Amgen Inc. | $14.44 | 07/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102322 | CMS |
| Amgen Inc. | $18.99 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228261883 | CMS |
| Amgen Inc. | $16.52 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228261881 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.60 | 08/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206175220 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.82 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207155226 | CMS |
| Exact Sciences Corporation | $23.95 | 04/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235264474 | CMS |
| Lilly USA, LLC | $25.05 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186899607 | CMS |
| Lilly USA, LLC | $16.52 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186910030 | CMS |
| Novo Nordisk Inc | $18.58 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188483233 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.